Screener
Theravance Biopharma TBPH Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on the most recent quarter.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's price / book?
- Theravance Biopharma (TBPH) reported price / book of 2.9× in Q1 2026.
- How has Theravance Biopharma's price / book changed year-over-year?
- Theravance Biopharma's price / book increased by 8.1% year-over-year, from 2.7× to 2.9×.
- What is the long-term trend for Theravance Biopharma's price / book?
- Over 3 years (2022 to 2025), Theravance Biopharma's price / book has grown at a 23.1% compound annual growth rate (CAGR), from 1.7× to 3.2×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Theravance Biopharma's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude